Skip to site menu Skip to page content
Curia Global
Go back

Thank you.

Please check your email to download the Product.

Controlled Substances

Developing and manufacturing scheduled compounds requires not only technical excellence but also rigorous security, licensing, and regulatory oversight. Curia offers comprehensive capabilities for the safe, compliant handling of DEA-controlled substances and regulated chemicals, supporting programs from development through commercial-scale production.

As a registered DEA partner, Curia provides a full range of services encompassing the manufacture, development, import, export, and analysis of Schedule I–V compounds, including stimulants such as phenidates and amphetamine derivatives, cannabinoids, narcotics, precursors, and intermediates. The company’s US operations feature DEA-approved secure infrastructure, including vaults, cages, and dedicated manufacturing areas, alongside a licensed aseptic fill-finish capability for scheduled materials.

Backed by a proven track record of specialised containment expertise, Curia serves as a trusted collaborator for complex controlled substance programmes, helping clients navigate demanding regulatory requirements while ensuring secure, high-quality supply.

Related Content